Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells

Molecules

Volumn 19, Issue 9, 2014, Pages 13976-13989

  Colotti, Gianni ^a,b   Poser, Elena ^b   Fiorillo, Annarita ^b   Genovese, Ilaria ^b   Chiarini, Valerio ^b   Ilari, Andrea ^a,b  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Brain; Calcium; Cancer; Endoplasmic reticulum; ER stress; Heart; Multi drug resistance in cancer; Neurodegenerative diseases; Ryanodine receptors; Sorcin

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; SRI PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; DRUG RESISTANCE; HEART MUSCLE; HUMAN; METABOLISM; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NEOPLASMS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; CALCIUM-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NEOPLASMS; ORGAN SPECIFICITY;

EID: 84907101340     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190913976     Document Type: Review

References (65)

1. Kawasaki, H.; Kretsinger, R.H. Calcium-binding proteins 1: EF-hands. Protein Profile 1995, 2, 297-490.
2. 2+-binding proteins. Biochim. Biophys. Acta 2002, 1600, 51-60.
3. Xie, X.; Dwyer, M.D.; Swenson, L.; Parker, M.H.; Botfield, M.C. Crystal structure of calcium-free human sorcin: A member of the penta-EF-hand protein family. Protein Sci. 2001, 10, 2419-2425.
4. 2+-dependent processes in the full-length protein. J. Mol. Biol. 2002, 317, 447-458.
5. Hansen, C.; Tarabykina, S.; la Cour, J.M.; Lollike, K.; Berchtold, M.W. The PEF family proteins sorcin and grancalcin interact in vivo and in vitro. FEBS Lett. 2003, 545, 151-154.
6. Franceschini, S.; Ilari, A.; Verzili, D.; Zamparelli, C.; Antaramian, A.; Rueda, A.; Valdivia, H.H.; Chiancone, E.; Colotti, G. Molecular basis for the impaired function of the natural F112L sorcin mutant: X-ray crystal structure, calcium affinity, and interaction with annexin VII and the ryanodine receptor. FASEB J. 2008, 22, 295-306.
7. Mella, M.; Colotti, G.; Zamparelli, C.; Verzili, D.; Ilari, A.; Chiancone, E. Information transfer in the penta-EF-hand protein sorcin does not operate via the canonical structural/functional pairing. A study with site-specific mutants. J. Biol. Chem. 2003, 278, 24921-24928.
8. 2+-dependent interaction with annexin VII and the cardiac ryanodine receptor. Biochemistry 2006, 45, 12519-12529.
9. Lalioti, V.S.; Ilari, A.; O'Connell, D.J.; Poser, E.; Sandoval, I.V.; Colotti, G. Sorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosis. PLoS One 2014, 9, e85438.
10. Landriscina, M.; Laudiero, G.; Maddalena, F.; Amoroso, M.R.; Piscazzi, A.; Cozzolino, F.; Monti, M.; Garbi, C.; Fersini, A.; Pucci, P.; et al. Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res. 2010, 70, 6577-6586.
11. Clapham, D.E. Calcium signaling. Cell 2007, 131, 1047-1058.
12. Zamparelli, C.; Ilari, A.; Verzili, D.; Giangiacomo, L.; Colotti, G.; Pascarella, S.; Chiancone, E. Structure-function relationships in sorcin, a member of the penta EF-hand family. Interaction of sorcin fragments with the ryanodine receptor and an Escherichia coli model system. Biochemistry 2000, 39, 658-666.
13. Meyers, M.B.; Pickel, V.M.; Sheu, S.S.; Sharma, V.K.; Scotto, K.W.; Fishman, G.I. Association of sorcin with the cardiac ryanodine receptor. J. Biol. Chem. 1995, 270, 26411-26418.
14. Lokuta, A.J.; Meyers, M.B.; Sander, P.R.; Fishman, G.I.; Valdivia, H.H. Modulation of cardiac ryanodine receptors by sorcin. J. Biol. Chem. 1997, 272, 25333-25338.
15. Seidler, T.; Miller, S.L.; Loughrey, C.M.; Kania, A.; Burow, A.; Kettlewell, S.; Teucher, N.; Wagner, S.; Kogler, H.; Meyers, M.B.; et al. Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes. Circ. Res. 2003, 93, 132-139.
16. 2+-ATPase and modulates excitation-contraction coupling in the heart. Basic Res. Cardiol. 2005, 100, 250-262.
17. 2+-binding domains. J. Mol. Cell. Cardiol. 2010, 49, 132-141.
18. 2+handling and reduces apoptosis in neonatal rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 2013, 304, C248-256.
19. Maddalena, F.; Sisinni, L.; Lettini, G.; Condelli, V.; Matassa, D.S.; Piscazzi, A.; Amoroso, M.R.; la Torre, G.; Esposito, F.; Landriscina, M. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol. Oncol. 2013, 7, 895-906.
20. 2+homeostasis. Cancer Res. 2011, 71, 7659-7669.
21. Anthony, D.F.; Beattie, J.; Paul, A.; Currie, S. Interaction of calcium/calmodulin-dependent protein kinase IIδC with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes. J. Mol. Cell. Cardiol. 2007, 43, 492-503.
22. ++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 2002, 99, 2569-2577.
23. Buschow, S.I.; van Balkom, B.W.; Aalberts, M.; Heck, A.J.; Wauben, M.; Stoorvogel, W. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol. Cell Biol. 2010, 88, 851-856.
24. Lai, R.C.; Chen, T.S.; Lim, S.K. Mesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease. Regen. Med. 2011, 6, 481-492.
25. Pisitkun, T.; Shen, R.F.; Knepper, M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
26. Gonzales, P.A.; Pisitkun, T.; Hoffert, J.D.; Tchapyjnikov, D.; Star, R.A.; Kleta, R.; Wang, N.S.; Knepper, M.A. Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 2009, 20, 363-379.
27. 2+ions in pancreatic β-cells. Diabetes 2012, 61, 574-585.
28. Van der Bliek, A.M.; Meyers, M.B.; Biedler, J.L.; Hes, E.; Borst, P. A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain. EMBO J. 1986, 5, 3201-3208.
29. Van der Bliek, A.M.; Baas, F.; van der Velde-Koerts, T.; Biedler, J.L.; Meyers, M.B.; Ozols, R.F.; Hamilton, T.C.; Joenje, H.; Borst, P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 1988, 48, 5927-5932.
30. Deng, L.; Su, T.; Leng, A.; Zhang, X.; Xu, M.; Yan, L.; Gu, H.; Zhang, G. Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med. Oncol. 2010, 27, 1102-1108.
31. Padar, S.; van Breemen, C.; Thomas, D.W.; Uchizono, J.A.; Livesey, J.C.; Rahimian, R. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone. Br. J. Pharmacol. 2004, 142, 305-316.
32. Qi, J.; Liu, N.; Zhou, Y.; Tan, Y.; Cheng, Y.; Yang, C.; Zhu, Z.; Xiong, D. Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem. Biophys. Res. Commun. 2006, 349, 303-309.
33. Qu, Y.; Yang, Y.; Liu, B.; Xiao, W. Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med. Oncol. 2010, 27, 1303-1308.
34. Tan, Y.; Li, G.; Zhao, C.; Wang, J.; Zhao, H.; Xue, Y.; Han, M.; Yang, C. Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk. Res. 2003, 27, 125-131.
35. Yamagishi, N.; Nakao, R.; Kondo, R.; Nishitsuji, M.; Saito, Y.; Kuga, T.; Hatayama, T.; Nakayama, Y. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein. Biochem. Biophys. Res. Commun. 2014, 448, 430-436.
36. Yang, Y.X.; Chen, Z.C.; Zhang, G.Y.; Yi, H.; Xiao, Z.Q. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J. Cell Biochem. 2008, 104, 1010-1021.
37. Zhou, Y.; Xu, Y.; Tan, Y.; Qi, J.; Xiao, Y.; Yang, C.; Zhu, Z.; Xiong, D. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk. Res. 2006, 30, 469-476.
38. Hamada, H.; Okochi, E.; Oh-hara, T.; Tsuruo, T. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res. 1988, 48, 3173-3178.
39. He, Q.; Zhang, G.; Hou, D.; Leng, A.; Xu, M.; Peng, J.; Liu, T. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp. Oncol. Rep. 2011, 25, 237-243.
40. Hu, Y.; Cheng, X.; Li, S.; Zhou, Y.; Wang, J.; Cheng, T.; Yang, M.; Xiong, D. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Cancer Chemother. Pharmacol. 2013, 72, 789-798.
41. Kawakami, M.; Nakamura, T.; Okamura, N.; Komoto, C.; Markova, S.; Kobayashi, H.; Hashimoto, N.; Okumura, K.; Sakaeda, T. Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biol. Pharm. Bull. 2007, 30, 1065-1073.
42. Liu, X.; Chen, L.; Feng, B.; Liu, G. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. Anat. Rec. 2014, 297, 215-221.
43. Parekh, H.K.; Deng, H.B.; Choudhary, K.; Houser, S.R.; Simpkins, H. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem. Pharmacol. 2002, 63, 1149-1158.
44. Hu, Y.; Li, S.; Yang, M.; Yan, C.; Fan, D.; Zhou, Y.; Zhang, Y.; Yague, E.; Xiong, D. Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo. Breast Cancer Res. Treat. 2014, 143, 287-299.
45. 2+and Na+ in normal and failing cardiac myocytes. Ann. N. Y. Acad. Sci. 2006, 1080, 165-177.
46. 2+current inactivation by sorcin in isolated rabbit cardiomyocytes. Pflugers Arch. 2009, 457, 1049-1060.
47. 2+current by functional interaction with the alpha1C subunit in rabbits. Exp. Physiol. 2008, 93, 1233-1238.
48. Farrell, E.F.; Antaramian, A.; Rueda, A.; Gomez, A.M.; Valdivia, H.H. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J. Biol. Chem. 2003, 278, 34660-34666.
49. Collis, L.P.; Meyers, M.B.; Zhang, J.; Phoon, C.K.; Sobie, E.A.; Coetzee, W.A.; Fishman, G.I. Expression of a sorcin missense mutation in the heart modulates excitation-contraction coupling. FASEB J. 2007, 21, 475-487.
50. Frank, K.F.; Bolck, B.; Ding, Z.; Krause, D.; Hattebuhr, N.; Malik, A.; Brixius, K.; Hajjar, R.J.; Schrader, J.; Schwinger, R.H. Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. J. Mol. Cell Cardiol. 2005, 38, 607-615.
51. Suarez, J.; Belke, D.D.; Gloss, B.; Dieterle, T.; McDonough, P.M.; Kim, Y.K.; Brunton, L.L.; Dillmann, W.H. In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H68-H75.
52. Yokota, T.; Kouno, J.; Adachi, K.; Takahashi, H.; Teramoto, A.; Matsumoto, K.; Sugisaki, Y.; Onda, M.; Tsunoda, T. Identification of histological markers for malignant glioma by genome-wide expression analysis: Dynein, alpha-PIX and sorcin. Acta Neuropathol. 2006, 111, 29-38.
53. French, P.J.; Swagemakers, S.M.; Nagel, J.H.; Kouwenhoven, M.C.; Brouwer, E.; van der Spek, P.; Luider, T.M.; Kros, J.M.; van den Bent, M.J.; Sillevis Smitt, P.A. Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res. 2005, 65, 11335-11344.
54. Shai, R.; Shi, T.; Kremen, T.J.; Horvath, S.; Liau, L.M.; Cloughesy, T.F.; Mischel, P.S.; Nelson, S.F. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 2003, 22, 4918-4923.
55. Sun, L.; Hui, A.M.; Su, Q.; Vortmeyer, A.; Kotliarov, Y.; Pastorino, S.; Passaniti, A.; Menon, J.; Walling, J.; Bailey, R.; et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9, 287-300.
56. Pomeroy, S.L.; Tamayo, P.; Gaasenbeek, M.; Sturla, L.M.; Angelo, M.; McLaughlin, M.E.; Kim, J.Y.; Goumnerova, L.C.; Black, P.M.; Lau, C.; et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415, 436-442.
57. Del Prete, D.; Checler, F.; Chami, M. Ryanodine receptors: Physiological function and deregulation in Alzheimer disease. Mol. Neurodegener 2014, 9, 21.
58. Pack-Chung, E.; Meyers, M.B.; Pettingell, W.P.; Moir, R.D.; Brownawell, A.M.; Cheng, I.; Tanzi, R.E.; Kim, T.W. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J. Biol. Chem. 2000, 275, 14440-14445.
59. Woods, W.S.; Boettcher, J.M.; Zhou, D.H.; Kloepper, K.D.; Hartman, K.L.; Ladror, D.T.; Qi, Z.; Rienstra, C.M.; George, J.M. Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy. J. Biol. Chem. 2007, 282, 34555-34567.
60. 2+leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006, 126, 981-993.
61. 2+signaling. FASEB J. 2005, 19, 2069-2071.
62. +-induced apoptosis in SH-SY5Y cells. Neurol. Sci. 2011, 32, 221-228.
63. Werner, C.J.; Heyny-von Haussen, R.; Mall, G.; Wolf, S. Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci. 2008, 6, 8.
64. Gracy, K.N.; Clarke, C.L.; Meyers, M.B.; Pickel, V.M. N-methyl-D-aspartate receptor 1 in the caudate-putamen nucleus: Ultrastructural localization and co-expression with sorcin, a 22,000 mol. wt calcium binding protein. Neuroscience 1999, 90, 107-117.
65. Clemen, C.S.; Herr, C.; Hovelmeyer, N.; Noegel, A.A. The lack of annexin A7 affects functions of primary astrocytes. Exp. Cell Res. 2003, 291, 406-414.